Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases
Clinical trial NCT05207904 · UNKNOWN
Trial details
- NCT number
- NCT05207904
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-17
- Primary completion
- 2022-12-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.